Moreover, an increased activity of mTOR was observed in the TRIM19−/− hematopoietic stem cells, and the mTOR inhibitor rapamycin substantially rescued the effect of TRIM19 deletion, suggesting that TRIM19 can exert its function in leukemia-initiating cells by inhibiting mTOR activity. The gene discussed is PML; the disease is leukemia.